Corporate venturing units from Cincinnati Children's Hospital Medical Center, Mayo Clinic and CincyTech reinvested in AssureRx in an $11m B round led by venture capital firms Claremont Creek Ventures and Sequoia Capital and joined by peer Allos Ventures.

Venture capital firm Intersouth Partners led the B round consortium for Advanced Animal Diagnostics, which included Novartis Venture Partners.

BioNanomatrix's previous investors, KT Venture Group, the corporate venturing unit of semiconductor equipment company KLA-Tencor, and non-profit research group Battelle Memorial Institute through its corporate venturing units Battelle Ventures and Innovation Valley Partners, reinvested in the $23.3m B round.

GlaxoSmithKline's corporate venturing team continues active deal rate with movement in its personnel.

American Medical Systems joins consortium investing $12.6m in US-based peer NxThera.

Embrella raised $6.7m in its series B round in August 2008 from New York-listed medical device maker Edwards Lifesciences and venture capital firms BioStar Ventures, MedFocus Fund and Hatteras Venture Partners.

Alongside Johnson & Johnson Development Corporation in Astute Medical's $13m B extension are venture capital firms Domain Associates, Delphi Ventures and De Novo Ventures.

Pontifax is chaired by Eli Hurvitz, chairman of local generic drugs maker Teva Pharmaceutical Industries, and has invested $1m in StimatixGI.

News provider VentureWire said venture capital firm Longitude Capital was leading CardioDx's series E round (which it said was raising $40m).

Liquidia previously raised more than $41m, including a $25m series C round in April from New York-listed clinical research organisation PPD and venture capital firms Canaan Partners, New Enterprise Associates, Morningside Venture Investments, Pappas Ventures and Firelake Capital.